Indoco Remedies’ AnaCipher gets ANVISA approval for clinical and bioanalytical facilities
The approval authorises the CRO to conduct bioavailability and bioequivalence studies for submission to Brazil, with associated…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Indoco Remedies
Indoco Remedies Goa Plant successfully clears Malta Medicines Authority audit
The facility has received EU GMP certification from the Malta Medicines Authority
Indoco Remedies clears Malta Medicines Authority audit
The facility has received EU GMP certification from the Malta Medicines Authority confirming that it complies with the Good…
Indoco Remedies announces strategic transfer of its ophthalmic division to Sunways India
Indoco Remedies has announced that in the Board Meeting conducted on 30th April, it has considered and approved the transfer of…
Friendshoring: Pharma’s next supply chain bet?
With friendshoring gaining attention in global supply chain conversations, this story looks at what it could mean for the India…
Indoco Remedies receives USFDA EIR for Patalganga API facility
USFDA inspection confirms compliance at Indoco Remedies’ Active Pharmaceutical Ingredients manufacturing site
Indoco’s API manufacturing facility at Patalganga completes US FDA inspection
Indoco Remedies Limited announced today that the United States Food and Drug Administration (USFDA) successfully completed…
Panel Discussion: Aligning packaging strategies with R&D
At the recently held PPL Conclave 2025 in Hyderabad, a panel discussion titled "Aligning Packaging Strategies with R&D"…
Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20…
Rivaroxaban Tablets USP will be manufactured at the company’s facility located in Goa
Indoco’s Goa Plant II gets EU GMP Compliance-certified
The facility, located in Verna Industrial Estate, manufactures sterile drug products